Latest Breaking News On - Margaret kaczor - Page 1 : comparemela.com

Abbott wins FDA clearance for its Lingo OTC glucose monitor

Abbott wins FDA clearance for its Lingo OTC glucose monitor
massdevice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massdevice.com Daily Mail and Mail on Sunday newspapers.

Margaret kaczorWilliam blair

Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript

Insulet Corporation (NASDAQ:PODD) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesJim hollingsheadPatrick woodWilliam blairJeff johnsonDeborah gordonMaria chadwickMichael polarkLarry biegelsenMargaret kaczor andrewRobbie marcusMargaret kaczorAbbott libreMorgan stanleyInsulet corporationInternational omnipod

Inogen, Inc (NASDAQ:INGN) Q1 2024 Earnings Call Transcript

Inogen, Inc (NASDAQ:INGN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Ryan petersonMathew blackmanMargaret kaczorWilliam blairColin clarkKevin smithMike bourqueExchange commissionKb internationalInogen incCall transcript mayFirst quarterInvestor relationsMost beautiful flags accordingUnderrated citiesHey colin

Penumbra, Inc (NYSE:PEN) Q1 2024 Earnings Call Transcript

Penumbra, Inc (NYSE:PEN) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesAdam elsesserWilliam blairMaggie yuenWilliam plovanicMargaret kaczorJoanne wuenschPenumbra incBusiness developmentCanaccord genuity fundCall transcript mayFirst quarterCecilia furlongInvestor relationsPrivate securities litigation reform actChief financial officer

Analysts remain high on ResMed despite potential GLP-1 benefits

William Blair analysts say that new data supporting GLP-1s for sleep apnea shouldn't displace companies like ResMed in the market.

James beersWilliam blair macauley kilbaneMargaret kaczorWilliam blairMacauley kilbane